Related Experiment Video

Updated: Nov 13, 2025

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome
06:48

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome

Published on: March 23, 2022

2.6K

Cronkhite–Canada syndrome

Anita Nagy1, Levente Tóth1, János Theisz1

  • 11 Szent Imre Egyetemi Oktatókórház, Gasztroenterológia Profil, Budapest, Tétényi út 12-16., 1115.

Orvosi Hetilap
|March 14, 2021
PubMed

Insights

Cronkhite-Canada syndrome is a rare noninherited disorder causing gastrointestinal polyposis and protein-losing enteropathy. This case report details a 71-year-old male diagnosed and treated for this condition.

Area of Science:

  • Gastroenterology
  • Internal Medicine
  • Rare Diseases

Background:

  • Cronkhite-Canada syndrome (CCS) is an extremely rare, noninherited disorder.
  • It is characterized by gastrointestinal polyposis, protein-losing enteropathy, and ectodermal abnormalities.
  • The etiology is largely unknown, with autoimmune mechanisms suspected.

Observation:

  • A case of a 71-year-old male patient presenting with symptoms suggestive of CCS.
  • Diagnosis was confirmed through patient history, physical examination, endoscopic findings, and histology.
  • This represents the first reported case of CCS in Hungary.

Findings:

  • The patient was diagnosed with Cronkhite-Canada syndrome.
  • Treatment involved a combination of proton-pump inhibitor, corticosteroids, and mesalazine.
  • Nutritional therapy was also administered as part of the management plan.

Implications:

  • This case highlights the importance of recognizing and diagnosing rare conditions like CCS.
  • The presented treatment regimen, based on literature, offers a potential therapeutic approach.
  • Further research into the etiology and optimal management of CCS is warranted.

Keywords:
Cronkhite–Canada syndromeCronkhite–Canada-szindrómafehérjevesztő enteropathiagastrointestinal polyposisonychodystrophiaonychodystrophypolyposisszindrómaprotein-losing enteropathy

More Related Videos

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

8.8K
Author Spotlight: Three-Dimensional Cephalometric Landmark Annotation Demonstration on Human Cone Beam Computed Tomography Scans10:23

Author Spotlight: Three-Dimensional Cephalometric Landmark Annotation Demonstration on Human Cone Beam Computed Tomography Scans

Published on: September 8, 2023

3.3K

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
284
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
130
Karyotyping01:17

Karyotyping

Overview
65.8K
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
344
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
173
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
532